TrianglePUBLICATIONS · 28684922
Emerging use of everolimus in the treatment of neuroendocrine tumors.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer Manag Res
- Publication date
- 2017
- First author
- Gajate P
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Gajate P
- type
- Author
- name
- Martínez-Sáez O
- type
- Author
- name
- Alonso-Gordoa T
- type
- Author
- name
- Grande E
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Gajate P
- type
- Author
- name
- Martínez-Sáez O
- type
- Author
- name
- Alonso-Gordoa T
- type
- Author
- name
- Grande E
- type
- Author
- bibliography ids
- nci-bib-f544c2d3ed5cd8c612360c1a
- book metadata
- content sha256
- 8426fded5898e2d4d463f02478ab9f9bef4bfde443e36da8d2731f38a8ebff0d
- document type
- citation
- dois
- 10.2147/CMAR.S113382
- electronic publication date
- display
- 2017 Jun 20
- precision
- day
- year
- 2017
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28684922
- immutable id
- pubmed:28684922@8426fded5898e2d4d463f02478ab9f9bef4bfde443e36da8d2731f38a8ebff0d
- journal
- abbreviation
- Cancer Manag Res
- issn electronic
- 1179-1322
- issn print
- 1179-1322
- issue
- Source null
- name
- Cancer management and research
- nlm unique id
- 101512700
- pages
- 215-224
- volume
- 9
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 28684922
- provenance
- batch id
- 1c173f0e18be0c6d461b
- provider
- NCBI PubMed ESummary
- record sha256
- 1f0fa57bbb76ee6a1b5e7226b706b53515e30d4f782d3cb0251c5e9c47f90b6f
- response sha256
- 27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
- retrieved at
- 2026-09-09T23:47:25.975513+00:00
- publication date
- display
- 2017
- precision
- year
- year
- 2017
- publication types
- Journal Article
- Review
- record status
- PubMed
- schema version
- 1.0
- title
- Emerging use of everolimus in the treatment of neuroendocrine tumors.
Preserved source evidence · Not medical advice